Valuation: SciBase Holding AB

Market Cap 273M 28.69M 24.77M 23.31M 21.18M 39.79M 2.74B 40.48M 107M 1.37B 108M 105M 4.6B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 273M 28.69M 24.77M 23.31M 21.18M 39.79M 2.74B 40.48M 107M 1.37B 108M 105M 4.6B EV / Sales 2026 *
4.14x
EV / Sales 2027 * 2.62x
Free-Float
77.22%
Yield 2026 *
-
Yield 2027 * -
1 day-0.74%
1 week-2.91%
Current month-10.40%
1 month-23.17%
3 months-43.19%
6 months+1.14%
Current year-22.61%
1 week 25.1
Extreme 25.1
29.1
1 month 25.1
Extreme 25.1
35.5
Current year 18.5
Extreme 18.5
54
1 year 18.5
Extreme 18.5
54
3 years 18.5
Extreme 18.5
129.8
5 years 18.5
Extreme 18.5
634
10 years 18.5
Extreme 18.5
3,020
Manager TitleAgeSince
Chief Executive Officer 59 01/10/2023
Director of Finance/CFO 64 01/01/2014
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Director/Board Member 60 16/05/2017
Chairman 66 13/06/2024
Director/Board Member 68 -
Change 5-day change 1-year change 3-year change Capi.($)
-0.74%-2.91%-29.37%-79.04% 28.75M
+1.02%+3.49%+20.90%-34.10% 17.03B
-2.98%+4.48%-7.86%+94.13% 1.82B
-5.24%-12.38%-47.19%-81.65% 1.03B
-0.44%-0.07%-30.41%+21.34% 985M
-0.05%+50.94%+72.97%-11.28% 780M
+0.95%+5.03%-36.88%-50.09% 690M
+3.92%+21.65%-39.26%-41.27% 622M
-0.99%+20.60%+41.99%+38.83% 418M
+5.89%+11.30%-41.31%-39.98% 417M
Average +0.13%+8.36%-9.64%-18.31% 2.38B
Weighted average by Cap. +0.47%+4.13%+11.31%-22.88%

Financials

2026 *2027 *
Net sales 65.9M 6.93M 5.98M 5.63M 5.11M 9.6M 661M 9.77M 25.75M 331M 26M 25.43M 1.11B 104M 10.95M 9.45M 8.89M 8.08M 15.18M 1.04B 15.45M 40.72M 524M 41.11M 40.21M 1.76B
Net income -66.3M -6.97M -6.02M -5.66M -5.14M -9.66M -665M -9.83M -25.91M -333M -26.16M -25.59M -1.12B -51.5M -5.41M -4.67M -4.4M -3.99M -7.5M -516M -7.64M -20.12M -259M -20.32M -19.88M -868M
Net Debt - -
Logo SciBase Holding AB
SciBase Holding AB (publ) is a Sweden-based company engaged in the medical equipment industry. The Company specializes in the manufacture of point of care device, called Nevisense, which is aimed to detect of malignant melanoma. Nevisense analyze suspicious lesions by using Electrical Impedance Spectroscopy (EIS) which is applied as an electrical signal to the skin. SciBase Holding AB (publ) specializes in early detection and prevention in dermatology. The Company develops and commercializes Nevisense, a point-of-care platform that combines AI (artificial intelligence) and advanced EIS technology to elevate diagnostic accuracy, ensuring proactive skin health management. SciBase Holding AB (publ) combines advanced EIS technology with AI to empower healthcare professionals by improving diagnostic precision, facilitating disease monitoring, and enabling early detection of skin cancer.
Employees
49
Date Price Change Volume
14/08/26 SEK 26.70 -0.74% 2,325
13/08/26 SEK 26.90 -2.54% 1,581
12/08/26 SEK 27.60 -2.13% 5,604
11/08/26 SEK 28.20 +0.71% 4,489
10/08/26 SEK 28.00 +0.36% 2,284

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. SCIB Stock